These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4920288)

  • 1. Pathophysiology and therapy of the shock of myocardial infarction.
    Haddy FJ
    Ann Intern Med; 1970 Nov; 73(5):809-27. PubMed ID: 4920288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shock in myocardial infarction--medical treatment.
    Kuhn LA
    Am J Cardiol; 1970 Dec; 26(6):578-87. PubMed ID: 4938984
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy in cardiogenic shock.
    Ramdohr B
    Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of shock in acute myocardial infarction.
    Pema PJ
    J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
    [No Abstract]   [Full Text] [Related]  

  • 5. Current concepts on mechanisms and treatment of cardiogenic shock.
    da Luz P; Weil MH; Shubin H
    Am Heart J; 1976 Jul; 92(1):103-13. PubMed ID: 785985
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of drugs in cardiogenic shock due to acute myocardial infarction.
    Gunnar RM; Loeb HS
    Circulation; 1972 May; 45(5):1111-24. PubMed ID: 4553612
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
    Kones RJ
    Angiology; 1974 May; 25(5):317-33. PubMed ID: 4150913
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.
    Mueller H; Ayres SM; Gregory JJ; Giannelli S; Grace WJ
    J Clin Invest; 1970 Oct; 49(10):1885-902. PubMed ID: 5460498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principle defects which account for shock following acute myocardial infarction in man: implications for treatment.
    Mueller H; Ayres SM; Grace WJ
    Crit Care Med; 1973; 1(1):27-38. PubMed ID: 4757962
    [No Abstract]   [Full Text] [Related]  

  • 10. The failing myocardium. I. Drug management.
    Loeb HS; Rahimtoola SH; Gunnar RM
    Med Clin North Am; 1973 Jan; 57(1):167-85. PubMed ID: 4143986
    [No Abstract]   [Full Text] [Related]  

  • 11. Inotropic agents in the treatment of cardiogenic shock.
    Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
    Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
    [No Abstract]   [Full Text] [Related]  

  • 12. Practical considerations in the management of shock complicating acute myocardial infarction. A summary of current practice.
    Shubin H; Weil MH
    Am J Cardiol; 1970 Dec; 26(6):603-8. PubMed ID: 4106755
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational therapeutic approach to cardiogenic shock.
    Wiener L
    Cardiovasc Clin; 1974; 6(2):223-37. PubMed ID: 4613459
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for cardiogenic shock.
    Promisloff R; Oaks WW
    Compr Ther; 1978 Nov; 4(11):49-56. PubMed ID: 720025
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiogenic shock].
    Trenckmann H
    Z Gesamte Inn Med; 1971 Jul; 26(13):Suppl:165-70. PubMed ID: 5125155
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiogenic shock and its current treatment.
    Willerson JT
    Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock. Recent advances in pharmacologic management. II.
    Kones RJ
    N Y State J Med; 1973 Aug; 73(15):1967-80. PubMed ID: 4354585
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
    Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
    Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy in cardiogenic shock].
    Wenger R
    Int J Clin Pharmacol; 1973 Apr; 7(2):127-31. PubMed ID: 4147221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.